Marshall BioResources

Marshall BioResources is the laboratory-animal brand of Marshall Farms Group Ltd, a private, family-owned company headquartered in North Rose, Wayne County, New York. The company traces its origins to 1939 when W. Gilman Marshall (Syracuse University, class of 1939) and his wife Ina Stevens Marshall founded the business with a focus on raising ferrets — initially for hunting small game and rodents, later for biomedical research (canine distemper vaccine development).

Scott Marshall serves as President and CEO of Marshall Farms Group, as confirmed in deposition testimony referenced in a 2022 Wayne County Supreme Court decision. The company's own materials emphasize that it “remain[s] a family-owned company.”

While exact revenues are undisclosed, multiple public records converge on an operation generating plausibly tens of millions of dollars annually across its combined animal-supply and affiliated business lines.

The principal US complex sits at 5800 Lake Bluff Road, North Rose, New York — the same address appearing in FMCSA transport records, USDA enforcement correspondence, and APHIS warning notices. This is the largest single beagle breeding facility in the world.

A March 2024 USDA inspection snapshot (cited in a PETA whistleblower complaint) documented approximately ~7,000 puppies and ~15,000 adult dogs on-site — totaling roughly 23,000 dogs at a single point in time. In addition to dogs, the facility houses large populations of ferrets and other species.

“Marshall Beagle” is a registered trademark (USPTO Reg. 2,571,901, Serial 75-781,950, applied August 23, 1999), not a recognized sub-breed. The beagle colony was established in 1962 and “officially closed” in 1967 — a genetics term meaning closed to outside introduction, creating a standardized, reproducible test population.

In toxicology and regulatory documentation, “Marshall beagle dogs” appears as a formal descriptor embedded in protocol templates and regulatory submissions:

Marshall is not solely a beagle breeder — it operates a multi-species colony system with shared logistics, compliance overhead, and customer relationships across research modalities. Dog-breeding operations exist within a broader platform.

Multiple secondary compilations assert that USDA cited Marshall for more than 20 Animal Welfare Act violations since 2007. A complete violation-by-violation inventory requires systematic extraction of APHIS inspection PDFs for license 21-A-0008 — no consolidated official spreadsheet exists.

Camp Beagle's 2023 “Beagle Imports” investigation, based on FOI requests to British and Danish authorities, documented over 6,000 beagles imported as cargo on Scandinavian Airlines (SAS) passenger planes over five years. All imports arrived at Copenhagen Airport and were distributed onward to seven European countries.

French advocacy group One Voice corroborated the findings, reporting that SAS imported 5,000 American dogs to European laboratories via Copenhagen since 2021, attributing the investigation to Camp Beagle and the Danish group Anima.

After the exposé, Camp Beagle claims subsequent FOI requests verified a halt (or near-halt) of beagle imports via Copenhagen. SAS did not make a formal public statement. Camp Beagle further asserted that after Envigo's closure in May 2022, Marshall became the sole importer of beagles for animal testing in Europe.

Marshall is a member of Understanding Animal Research (UK), positioning the company within a pro-animal-research public affairs ecosystem rather than a neutral supplier posture. Its marketing frames its animals as contributing to “life saving therapies and treatments for humans and animals,” implying distinct customer clusters in human drug/chemical safety evaluation and veterinary product development.

European conference materials reflect a service ecosystem around the canine model, including “supply of Marshall Beagle” within CRO-style service offerings at events such as FELASA 2022.